Live view of SEC fundamentals with peer-based benchmarks and implied valuation gaps.
Current Price
Live market data for NVDA
Implied Value
Based on CVS P/E multiple
| Metric | NVDA | Delta vs CVS | CVS | Context |
|---|---|---|---|---|
Revenue growth (LTM) | 114.2% | 2618.0% higher | 4.2% | Growth edge |
Gross margin | 75.0% | 879.4% higher | 7.7% | Pricing power |
EBITDA margin | 66.2% | 1408.4% higher | 4.4% | Operating leverage |
EV/Revenue | 34.61x | 8381.9% higher | 0.41x | Multiple premium |
P/E | 63.44x | 202.2% higher | 20.99x | Premium justified |
Net debt / EBITDA | -0.4 | 111.5% lower | 3.4 | Lower leverage |
Quality signals that explain why a cheap stock might stay cheap.
Bottom-right quadrant is the sweet spot: high growth, low valuation.
NVDA CIK: 1045810
CVS CIK: 64803